COST COMPARISON OF LINEZOLID VERSUS VANCOMYCIN FOR TREATMENT OF NOSOCOMIAL PNEUMONIA AND COMPLICATED SKIN AND SOFT TISSUE INFECTION CAUSED BY MRSA IN QUEBEC

被引：0
|
作者：
Pettigrew, M. [1 ]
Thirion, D. J. [2 ]
Libman, M. [3 ]
Zanotti, G. [4 ]
机构：
[1] Symbiose, Montreal, PQ, Canada
[2] Univ Montreal, Montreal, PQ, Canada
[3] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[4] Pfizer Canada Inc, Kirkland, PQ, Canada
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.648
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A116 / A116
页数：1
相关论文
共 50 条
  • [1] Linezolid versus vancomycin for MRSA nosocomial pneumonia
    不详
    FUTURE MICROBIOLOGY, 2010, 5 (12) : 1763 - 1763
  • [2] Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections
    Weigelt, J
    Itani, K
    Stevens, D
    Lau, W
    Dryden, M
    Knirsch, C
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) : 2260 - 2266
  • [3] Cost comparison of linezolid versus vancomycin for treatment of complicated skin and skin-structure infection caused by methicillin-resistant Staphylococcus aureus in Quebec
    Pettigrew, Martine
    Thirion, Daniel J. G.
    Libman, Michael
    Zanotti, Giovanni
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2012, 23 (04): : 187 - 195
  • [4] Effectiveness of linezolid versus vancomycin treatment for MRSA skin and soft tissue infections
    Yim, M.
    Steingisser, J.
    Kan, R.
    Nshala, A.
    Larson, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E394 - E394
  • [5] TREATMENT OF MRSA PNEUMONIA: ECONOMICAL AND CLINICAL COMPARISON OF LINEZOLID VERSUS VANCOMYCIN
    Wilke, M.
    Petrik, C.
    Weber, B.
    Kloss, S.
    VALUE IN HEALTH, 2014, 17 (07) : A669 - A669
  • [6] Cost-effectiveness of linezolid versus vancomycin in the treatment of nosocomial pneumonia in Argentina
    Aiello, EC
    Barcelona, LI
    De Vedia, L
    Stamboulian, D
    VALUE IN HEALTH, 2006, 9 (03) : A155 - A156
  • [7] The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid
    Stein, Gary E.
    Wells, Elizabeth M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (03) : 571 - 588
  • [8] LINEZOLID FOR THE TREATMENT OF PATIENTS WITH CONFIRMED MRSA NOSOCOMIAL PNEUMONIA IN NANJING, CHINA: A COST EFFECTIVE ALTERNATIVE TO VANCOMYCIN
    Tan, S. C.
    Li, Q.
    Chen, Y.
    Hajek, P.
    Weinstein, D.
    Patel, D. A.
    VALUE IN HEALTH, 2013, 16 (07) : A353 - A353
  • [9] Linezolid versus vancomycin for skin and soft tissue infections
    Yue, Jirong
    Dong, Bi Rong
    Yang, Ming
    Chen, Xiaomei
    Wu, Taixiang
    Liu, Guan J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01):
  • [10] Linezolid versus vancomycin for skin and soft tissue infections
    Yue, Jirong
    Dong, Bi Rong
    Yang, Ming
    Chen, Xiaomei
    Wu, Taixiang
    Liu, Guan J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (07):
12345